Zentalis Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $252,552,000.
Profit Margin
| 2018 | 14K | -21.06M | -150478.57% |
|---|---|---|---|
| 2019 | 0 | -46.37M | |
| 2020 | 0 | -118.54M | |
| 2021 | 0 | -164.26M | |
| 2022 | 0 | -220.83M | |
| 2023 | 0 | -292.19M |
ZNTL Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 14K |
Cost of revenue | 1.38M | 1.42M | 544K | 160K | 111K | 0 |
Gross profit | -1.38M | -1.42M | -544K | -160K | -111K | 14K |
Operating exp. | ||||||
Research and development | 189.59M | 172.73M | 175.60M | 84.90M | 38.38M | 18.92M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 252.55M | 227.28M | 216.54M | 118.78M | 46.84M | 23.79M |
Operating income | -248.98M | -227.28M | -216.54M | -118.78M | -46.84M | -23.78M |
Other income (expenses), net | -27.90M | 5.98M | 51.98M | 683K | 482K | 355K |
Income before tax | -276.89M | -221.3M | -164.55M | -118.10M | -46.36M | -23.42M |
Income tax expense | -601K | -469K | -297K | 444K | 15K | 4K |
Net income | -292.19M | -220.83M | -164.26M | -118.54M | -46.37M | -21.06M |
Earnings per share | ||||||
Basic EPS | -4.47 | -4.18 | -3.85 | -2.89 | -1.29 | -1.17 |
Diluted EPS | -4.47 | -4.18 | -3.85 | -2.89 | -1.29 | -1.17 |
| Data source | Data source | Data source | Data source |